Drug Discovery and Development Interview with Dr. Alex Feoktistov on new treatment options.

FDA approves Rizafilm, the first oral thin film using IntelGenx proprietary drug delivery technology, for the acute treatment of migraine with or without aura.

The prescription wearable neuromodulation device, Nerivio, was recently cleared by the FDA for preventive treatment of migraine.

Struggles to get to the clinic? Trying to reduce your exposure to COVID-19? Telehealth is safe and easy — receive quality care from anywhere. If you live in Illinois, California, or Florida we could see you via our secure telehealth platform.

FDA has approved a new nasal spray for acute treatment of migraine in adults.

A brief discussion about a balanced approach to migraine treatment that may include lifestyle modifications, medications, and the state-of-the-art approved neuromodulation devices that may help treat and prevent migraine attacks.

Dr. Alex's interview with MassDevice medical network about novel options in migraine management: CGRP active drugs and non-invasive neuromodulation devices approved for migraine treatment.